Edwards Lifesciences Corporation (EW)
NYSE: EW · IEX Real-Time Price · USD
95.56
+0.41 (0.43%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for EW stock have an average target of 90.18, with a low estimate of 57 and a high estimate of 107. The average target predicts a decrease of -5.63% from the current stock price of 95.56.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for EW stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 3 | 3 | 4 |
Buy | 7 | 7 | 7 | 7 | 8 | 8 |
Hold | 9 | 7 | 8 | 9 | 6 | 6 |
Sell | 0 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 19 | 19 | 20 | 18 | 19 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Buy Maintains $95 → $103 | Buy | Maintains | $95 → $103 | +7.79% | Mar 21, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $93 → $100 | Buy | Maintains | $93 → $100 | +4.65% | Mar 18, 2024 |
B of A Securities | B of A Securities | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 7, 2024 |
Stifel | Stifel | Hold Maintains $70 → $83 | Hold | Maintains | $70 → $83 | -13.14% | Feb 7, 2024 |
Morgan Stanley | Morgan Stanley | Buy Maintains $80 → $95 | Buy | Maintains | $80 → $95 | -0.59% | Feb 7, 2024 |
Financial Forecast
Revenue This Year
6.72B
from 6.00B
Increased by 11.88%
Revenue Next Year
7.38B
from 6.72B
Increased by 9.78%
EPS This Year
2.84
from 2.30
Increased by 23.30%
EPS Next Year
3.18
from 2.84
Increased by 12.29%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 6.9B | 7.7B | 8.6B | 9.6B | 10.8B |
Avg | 6.7B | 7.4B | 8.1B | 8.9B | 10.1B |
Low | 6.3B | 6.8B | 7.3B | 8.0B | 9.3B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 15.5% | 15.3% | 16.5% | 18.7% | 21.2% |
Avg | 11.9% | 9.8% | 9.3% | 10.3% | 13.2% |
Low | 5.2% | 1.4% | -0.5% | -0.6% | 4.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.94 | 3.40 | 3.93 | 4.73 | 5.35 |
Avg | 2.84 | 3.18 | 3.54 | 4.07 | 4.79 |
Low | 2.60 | 2.82 | 3.08 | 3.66 | 4.21 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 27.9% | 19.9% | 23.6% | 33.4% | 31.5% |
Avg | 23.3% | 12.3% | 11.2% | 15.0% | 17.6% |
Low | 12.9% | -0.5% | -3.4% | 3.2% | 3.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.